Anti-Galectin 8/Gal-8 antibody [EPR4857]
- RabMAb
- Recombinant
- What is this?
4
(4 Reviews)
|
(23 Publications)
Rabbit Recombinant Monoclonal Galectin 8/Gal-8 antibody. Suitable for IHC-P, IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Recombinant fragment samples. Cited in 23 publications.
View Alternative Names
Galectin-8, Gal-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1, Po66-CBP, PCTA-1, LGALS8
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Galectin 8/Gal-8 antibody [EPR4857] (AB109519)
Unpurified ab109519, at a 1/100 dilution, staining Human prostatic adenocarcinoma, using Immunohistochemstry, Formalin/PFA-fixed paraffin-embedded tissue.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Galectin 8/Gal-8 antibody [EPR4857] (AB109519)
ab109519 staining Galectin 8/Gal-8 in the human cell line HEK293 (human embryonic kidney) by intracellular flow cytometry. Cells were fixed with 4% paraformaldehyde and the sample was incubated with the primary antibody at a dilution of 1/100. A goat anti rabbit IgG (Alexa Fluor® 488) at a dilution of 1/500 was used as the secondary antibody.
Isoytype control : Rabbit monoclonal IgG (Black)
Unlabelled control : Cell without incubation with primary antibody and secondary antibody (Blue)
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Galectin 8/Gal-8 antibody [EPR4857] (AB109519)
ab109519 staining Galectin 8/Gal-8 in HeLa (human cervix adenocarcinoma) cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. Samples were incubated with primary antibody at a dilution of 1/100. A goat anti rabbit IgG (Alexa Fluor® 488) (ab150077) was used as the secondary antibody at a dilution of 1/1000. ab7291 and ab150120 were used as counterstains for primary antibody ab109519 and secondary antibody ab150077 respectively and DAPI was used as a nuclear counterstain.
Negative control 1 : Rabbit primary antibody and anti-mouse secondary antibody (ab150120)
Negative control 2 : Mouse primary antibody (ab7291) and anti-rabbit secondary antibody (ab150077)
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Galectin 8/Gal-8 antibody [EPR4857] (AB109519)
Overlay histogram showing HeLa cells stained with unpurified ab109519 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab109519, 1/100) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Galectin 8/Gal-8 antibody [EPR4857] (AB109519)
ab109519 staining Galectin 8/Gal-8 in human prostatic carcinoma tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde and antigen retrieval was by heat mediation in a EDTA buffer. Samples were incubated with primary antibody at a dilution of 1/250. A goat anti-rabbit IgG H&L (HRP) ab97051 was used as the secondary antibody at a dilution of 1/500.
Negative control 1 : PBS in place of primary antibody.
- IP
Lab
Immunoprecipitation - Anti-Galectin 8/Gal-8 antibody [EPR4857] (AB109519)
Purified ab109519 at 1/30 dilution (2μg) immunoprecipitating Galectin 8/Gal-8 in HeLa whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab109519 + HeLa whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab109519 in HeLa whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/10,000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 36/40 kDa
All lanes:
Immunoprecipitation - Anti-Galectin 8/Gal-8 antibody [EPR4857] (ab109519)
Predicted band size: 36 kDa
false
- WB
Unknown
Western blot - Anti-Galectin 8/Gal-8 antibody [EPR4857] (AB109519)
All lanes:
Western blot - Anti-Galectin 8/Gal-8 antibody [EPR4857] (ab109519) at 1/1000 dilution
Lane 1:
HepG2 cell lysate at 10 µg
Lane 2:
LNCaP cell lysate at 10 µg
Predicted band size: 36 kDa,68 kDa
Observed band size: 68 kDa
false
- WB
Unknown
Western blot - Anti-Galectin 8/Gal-8 antibody [EPR4857] (AB109519)
Blocking and diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-Galectin 8/Gal-8 antibody [EPR4857] (ab109519) at 1/10000 dilution
All lanes:
LNCAP (human prostat carcinoma) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 36 kDa
Observed band size: 40 kDa
false
- WB
Supplier Data
Western blot - Anti-Galectin 8/Gal-8 antibody [EPR4857] (AB109519)
ab109519 has weak cross-reactivity with Galectin 9.
Lanes 1 and 3:
unpurified at 1/1000 dilution
Lane 2:
Western blot - Anti-Galectin 8/Gal-8 antibody [EPR4857] (ab109519) at 1/200 dilution
All lanes:
Galectin 9 recombinant protein at 0.02 µg
Predicted band size: 36 kDa
false
- WB
Unknown
Western blot - Anti-Galectin 8/Gal-8 antibody [EPR4857] (AB109519)
All lanes:
Western blot - Anti-Galectin 8/Gal-8 antibody [EPR4857] (ab109519) at 1/5000 dilution
All lanes:
Western blot - Recombinant Human Galectin 8/Gal-8 protein (His tag N-Terminus) (<a href='/en-us/products/proteins-peptides/recombinant-human-galectin-8-gal-8-protein-ab99294'>ab99294</a>) at 0.1 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution
Predicted band size: 36 kDa
true
Exposure time: 90s
Related conjugates and formulations (10)
-
Anti-Galectin 8/Gal-8 antibody [EPR4857] - BSA and Azide free
-
578 PE
PE Anti-Galectin 8 / Gal-8 antibody [EPR4857]
-
660 APC
APC Anti-Galectin 8 / Gal-8 antibody [EPR4857]
-
HRP Anti-Galectin 8 / Gal-8 antibody [EPR4857]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Galectin 8 / Gal-8 antibody [EPR4857]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Galectin 8 / Gal-8 antibody [EPR4857]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Galectin 8 / Gal-8 antibody [EPR4857]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-Galectin 8 / Gal-8 antibody [EPR4857]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Galectin 8 / Gal-8 antibody [EPR4857]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Galectin 8/Gal-8 antibody [EPR4857]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Galectin-8 impacts numerous cellular functions through its involvement in immunomodulation and cell migration. Gal-8 promotes adhesion between cells and the extracellular matrix. It is not a part of a larger protein complex but interacts with multiple cell surface receptors guiding them toward or away from specific locations. Galectins including Galectin-8 influence immune cell responses by managing the apoptosis of T-cells and modifying cytokine production.
Pathways
Galectin-8 engages in signaling pathways related to cellular adhesion and immune system modulation. It participates in the integrin-mediated cell adhesion pathway and contributes to the receptor signaling pathway associated with cytokines. Within these pathways Galectin-8 interacts with other proteins such as integrins and T-cell receptors influencing their activation internalization and cell surface retention.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (23)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in neurology 15:1483016 PubMed39722688
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed39000016
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 221: PubMed38517332
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 22:175 PubMed38468333
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 12: PubMed38397905
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 5:101374 PubMed38232701
2024
Applications
Unspecified application
Species
Unspecified reactive species
Diagnostics (Basel, Switzerland) 13: PubMed37892036
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:106984 PubMed37534161
2023
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 13:2517-2529 PubMed37424827
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37298652
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com